NCT07262047

Brief Summary

In this study, we aim to assess the QOL of pediatric IEI patients compared with healthy controls and to determine different factors affecting QOL in these patients.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
5mo left

Started Dec 2025

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress50%
Dec 2025Oct 2026

First Submitted

Initial submission to the registry

November 22, 2025

Completed
9 days until next milestone

Study Start

First participant enrolled

December 1, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 3, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 10, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2026

Last Updated

December 3, 2025

Status Verified

November 1, 2025

Enrollment Period

8 months

First QC Date

November 22, 2025

Last Update Submit

November 22, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Arabic version of PedsQL, version 4

    The tool is composed of 23 items that cover the following domains: physical, emotional, social, and school functioning. Each item is on a 5-point Likert scale ranging between 0 and 4 (0= never, 1= almost never, 2= sometimes, 3= often, 4= almost always). Scores are linearly transformed to a 0- to 100- point scale (4 = 0, 3 = 25, 2 = 50, 1 = 75, 0= 100) and higher scores reflect a better HRQOL.

    At enrollment

Interventions

Administration of standardized quality-of-life questionnaires (e.g., PedsQL) to children with primary immunodeficiency and/or their caregivers.

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children diagnosed with primary immunodeficiency who are followed at participating immunology clinics or hospitals.

You may qualify if:

  • children from 6 years untill 18 years

You may not qualify if:

  • failed to get a consent not appropriate age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (4)

  • Bousfiha A, Jeddane L, Al-Herz W, Ailal F, Casanova JL, Chatila T, Conley ME, Cunningham-Rundles C, Etzioni A, Franco JL, Gaspar HB, Holland SM, Klein C, Nonoyama S, Ochs HD, Oksenhendler E, Picard C, Puck JM, Sullivan KE, Tang ML. The 2015 IUIS Phenotypic Classification for Primary Immunodeficiencies. J Clin Immunol. 2015 Nov;35(8):727-38. doi: 10.1007/s10875-015-0198-5. Epub 2015 Oct 7.

    PMID: 26445875BACKGROUND
  • de Vries E, Driessen G. Educational paper: Primary immunodeficiencies in children: a diagnostic challenge. Eur J Pediatr. 2011 Feb;170(2):169-77. doi: 10.1007/s00431-010-1358-5. Epub 2010 Dec 18.

    PMID: 21170549BACKGROUND
  • Tangye SG, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco JL, Holland SM, Klein C, Morio T, Oksenhendler E, Picard C, Puel A, Puck J, Seppanen MRJ, Somech R, Su HC, Sullivan KE, Torgerson TR, Meyts I. Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2022 Oct;42(7):1473-1507. doi: 10.1007/s10875-022-01289-3. Epub 2022 Jun 24.

    PMID: 35748970BACKGROUND
  • Picard C, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, Cunningham-Rundles C, Etzioni A, Holland SM, Klein C, Nonoyama S, Ochs HD, Oksenhendler E, Puck JM, Sullivan KE, Tang ML, Franco JL, Gaspar HB. Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol. 2015 Nov;35(8):696-726. doi: 10.1007/s10875-015-0201-1. Epub 2015 Oct 19.

    PMID: 26482257BACKGROUND

MeSH Terms

Conditions

Primary Immunodeficiency Diseases

Condition Hierarchy (Ancestors)

Genetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • eman mohamed fahmy

    Sohag University

    STUDY DIRECTOR

Central Study Contacts

Ahmed mohamed Ali, principle investigator

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
doctor

Study Record Dates

First Submitted

November 22, 2025

First Posted

December 3, 2025

Study Start

December 1, 2025

Primary Completion (Estimated)

August 10, 2026

Study Completion (Estimated)

October 10, 2026

Last Updated

December 3, 2025

Record last verified: 2025-11